Venture Capital-backed Zymeworks Goes Public

    Venture Capital-backed Zymeworks Goes Public

Vancouver-based Zymeworks (TSE/NYSE: ZYME) debuted on the public markets last Friday, just two weeks after announcing its intention to go public. The company raised CAD $79.7 million in the IPO

Read Full Article

Aurinia completes $52M private placement

Aurinia Pharmaceuticals Inc. (TSX-V:AUP) has announced completion of a $52 million (US) private placement, subject to regulatory approval. The financing was led by venBio, New Enterprise Associates (NEA), Redmile Group,

Read Full Article

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter